Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.
Jandu H, Aluzaite K, Fogh L, Thrane SW, Noer JB, Proszek J, Do KN, Hansen SN, Damsgaard B, Nielsen SL, Stougaard M, Knudsen BR, Moreira J, Hamerlik P, Gajjar M, Smid M, Martens J, Foekens J, Pommier Y, Brünner N, Schrohl AS, Stenvang J.
Jandu H, et al.
BMC Cancer. 2016 Jan 22;16:34. doi: 10.1186/s12885-016-2071-1.
BMC Cancer. 2016.
PMID: 26801902
Free PMC article.